Immunotherapy Oral Abstracts
Thursday, May 30, 2024 09:15 AM - 10:15 AM
Room 202-204
Immunotherapy (CAR-T, T Reg, NK Cells etc.)
Abstract Presentations
- Chimeric Antigen Receptor (CAR) T cell therapy for aspergillosis., Pappanaicken Kumar, United States
- Expansion and Characterization of Immune Suppresive CD56BRIGHTCD16- Regulatory Natural Killer Cells For Chronic Graft-Versus-Host Disease (CGVHD)., Madeline Lauener, Canada
- First-In-Human Phase I/II Clinical Trial of IG-TRegs for GHVD Prevention, Memnon Lysandrou, Cyprus
- Single-Cell Transcriptome Analysis Reveals Distinct Characteristics Of Anti-CD22 CAR T-Cell Infusion Products Associated With Efficacy And Toxicity, lipei shao, United States
- Engineering autologous glioblastoma-specific T cells using nanoparticle-based photothermal therapy, Elizabeth E. Sweeney, United States
- Genetic Engineering of Gamma Delta (γδ) T Cells with the IL-2 Cytokine Receptor Orthogonal Pair (OIL-2R/OIL-2) as Immunotherapy for Pediatric Acute Myeloid Leukemia (AML), Wenjun Wang, United States
